Medtech interviewed Sarah Sorrel, a leading EU expert and consultant on clinical data issues to better understand what Post-market clinical follow-up (PMCF), a relatively new requirement for the EU medtech sector, will entail. Sorrell, president of MedPass International, discusses how slow implementation of the new regulations is making it difficult for manufacturers to put post-market plans into place and leverage the potential value of PMCF to help obtain recertification of devices. The interview previews some of the themes at the 3rd European Symposium on New Medical Device Regulations in Brussels.